Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?

Recently, an increasing number of novel drugs were approved in oncology and hematology. Nevertheless, pharmacology progress comes with a variety of side effects, of which cytokine release syndrome (CRS) is a potential complication of some immunotherapies that can lead to multiorgan failure if not di...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Constantinescu, Catalin, Pasca, Sergiu, Tat, Tiberiu, Teodorescu, Patric, Vlad, Catalin, Iluta, Sabina, Dima, Delia, Tomescu, Dana, Scarlatescu, Ecaterina, Tanase, Alina, Sigurjonsson, Olafur Eysteinn, Colita, Anca, Einsele, Hermann, Tomuleasa, Ciprian
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Hypothesis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264828/
https://ncbi.nlm.nih.gov/pubmed/32474415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000742
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados